rs753541585
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP6
The NM_016824.5(ADD3):c.*2_*5delTAAA variant causes a 3 prime UTR change. The variant allele was found at a frequency of 0.000251 in 1,570,816 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00025 ( 0 hom. )
Consequence
ADD3
NM_016824.5 3_prime_UTR
NM_016824.5 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.44
Publications
0 publications found
Genes affected
ADD3 (HGNC:245): (adducin 3) Adducins are heteromeric proteins composed of different subunits referred to as adducin alpha, beta and gamma. The three subunits are encoded by distinct genes and belong to a family of membrane skeletal proteins involved in the assembly of spectrin-actin network in erythrocytes and at sites of cell-cell contact in epithelial tissues. While adducins alpha and gamma are ubiquitously expressed, the expression of adducin beta is restricted to brain and hematopoietic tissues. Adducin, originally purified from human erythrocytes, was found to be a heterodimer of adducins alpha and beta. Polymorphisms resulting in amino acid substitutions in these two subunits have been associated with the regulation of blood pressure in an animal model of hypertension. Heterodimers consisting of alpha and gamma subunits have also been described. Structurally, each subunit is comprised of two distinct domains. The amino-terminal region is protease resistant and globular in shape, while the carboxy-terminal region is protease sensitive. The latter contains multiple phosphorylation sites for protein kinase C, the binding site for calmodulin, and is required for association with spectrin and actin. Alternatively spliced adducin gamma transcripts encoding different isoforms have been described. The functions of the different isoforms are not known. [provided by RefSeq, Jul 2008]
ADD3 Gene-Disease associations (from GenCC):
- cerebral palsy, spastic quadriplegic, 3Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- complex neurodevelopmental disorder with motor featuresInheritance: AR Classification: MODERATE Submitted by: ClinGen
- spastic quadriplegic cerebral palsyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -1 ACMG points.
BP6
Variant 10-110133615-CTAAA-C is Benign according to our data. Variant chr10-110133615-CTAAA-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 445451.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ADD3 | ENST00000356080.9 | c.*2_*5delTAAA | 3_prime_UTR_variant | Exon 15 of 15 | 1 | NM_016824.5 | ENSP00000348381.4 | |||
| ADD3 | ENST00000277900.12 | c.*2_*5delTAAA | 3_prime_UTR_variant | Exon 14 of 14 | 1 | ENSP00000277900.8 | ||||
| ADD3 | ENST00000360162.7 | c.*2_*5delTAAA | 3_prime_UTR_variant | Exon 14 of 14 | 1 | ENSP00000353286.3 |
Frequencies
GnomAD3 genomes AF: 0.000263 AC: 40AN: 152078Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
40
AN:
152078
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000359 AC: 77AN: 214620 AF XY: 0.000349 show subpopulations
GnomAD2 exomes
AF:
AC:
77
AN:
214620
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000250 AC: 354AN: 1418738Hom.: 0 AF XY: 0.000253 AC XY: 178AN XY: 703960 show subpopulations
GnomAD4 exome
AF:
AC:
354
AN:
1418738
Hom.:
AF XY:
AC XY:
178
AN XY:
703960
show subpopulations
African (AFR)
AF:
AC:
3
AN:
31148
American (AMR)
AF:
AC:
4
AN:
35390
Ashkenazi Jewish (ASJ)
AF:
AC:
100
AN:
24278
East Asian (EAS)
AF:
AC:
1
AN:
39342
South Asian (SAS)
AF:
AC:
8
AN:
79050
European-Finnish (FIN)
AF:
AC:
0
AN:
48772
Middle Eastern (MID)
AF:
AC:
29
AN:
5544
European-Non Finnish (NFE)
AF:
AC:
170
AN:
1096694
Other (OTH)
AF:
AC:
39
AN:
58520
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
16
33
49
66
82
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000263 AC: 40AN: 152078Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74288 show subpopulations
GnomAD4 genome
AF:
AC:
40
AN:
152078
Hom.:
Cov.:
32
AF XY:
AC XY:
13
AN XY:
74288
show subpopulations
African (AFR)
AF:
AC:
4
AN:
41400
American (AMR)
AF:
AC:
3
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
AC:
12
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5192
South Asian (SAS)
AF:
AC:
0
AN:
4816
European-Finnish (FIN)
AF:
AC:
0
AN:
10598
Middle Eastern (MID)
AF:
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
AC:
19
AN:
68022
Other (OTH)
AF:
AC:
2
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:2Benign:1
Feb 22, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Oct 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.